Avatar Mice Underscore the Role of the T Cell-Dendritic Cell Crosstalk in Ebola Virus Disease and Reveal Mechanisms of Protection in Survivors.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
28 09 2022
Historique:
pubmed: 9 9 2022
medline: 1 10 2022
entrez: 8 9 2022
Statut: ppublish

Résumé

Ebola virus disease (EVD) is a complex infectious disease characterized by high inflammation, multiorgan failure, the dysregulation of innate and adaptive immune responses, and coagulation abnormalities. Evidence accumulated over the last 2 decades indicates that, during fatal EVD, the infection of antigen-presenting cells (APC) and the dysregulation of T cell immunity preclude a successful transition between innate and adaptive immunity, which constitutes a key disease checkpoint. In order to better understand the contribution of the APC-T cell crosstalk to EVD pathophysiology, we have developed avatar mice transplanted with human, donor-specific APCs and T cells. Here, we show that the transplantation of T cells and APCs from Ebola virus (EBOV)-naive individuals into avatar mice results in severe disease and death and that this phenotype is dependent on T cell receptor (TCR)-major histocompatibility complex (MCH) recognition. Conversely, avatar mice were rescued from death induced by EBOV infection after the transplantation of both T cells and plasma from EVD survivors. These results strongly suggest that protection from EBOV reinfection requires both cellular and humoral immune memory responses.

Identifiants

pubmed: 36073921
doi: 10.1128/jvi.00574-22
pmc: PMC9517696
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0057422

Références

J Neuroimmune Pharmacol. 2011 Mar;6(1):148-57
pubmed: 20532647
Nature. 1999 Oct 14;401(6754):708-12
pubmed: 10537110
Sci Rep. 2017 Mar 03;7:43776
pubmed: 28256637
Cell Host Microbe. 2019 Jan 9;25(1):39-48.e5
pubmed: 30629917
J Virol. 2003 Jul;77(14):7945-56
pubmed: 12829834
Immunity. 2013 Jan 24;38(1):187-97
pubmed: 23260195
Adv Immunol. 2013;120:1-49
pubmed: 24070379
J Immunol. 2010 Jan 1;184(1):327-35
pubmed: 20028660
Blood. 2002 Jul 15;100(2):701-3
pubmed: 12091369
J Immunol. 2003 Mar 15;170(6):2797-801
pubmed: 12626527
Lancet. 2021 Feb 27;397(10276):781
pubmed: 33640050
J Infect Dis. 2018 Nov 22;218(suppl_5):S409-S417
pubmed: 30085162
Nature. 1998 Mar 19;392(6673):245-52
pubmed: 9521319
Curr Top Microbiol Immunol. 2017;411:141-169
pubmed: 28653186
Proc Natl Acad Sci U S A. 2015 Apr 14;112(15):4719-24
pubmed: 25775592
Cell. 2011 Sep 16;146(6):861-2
pubmed: 21925310
Sci Rep. 2017 Nov 7;7(1):14756
pubmed: 29116224
Curr Opin Virol. 2017 Aug;25:90-96
pubmed: 28810165
Nature. 2018 Oct;562(7726):192
pubmed: 30305752
J Infect Dis. 2016 Oct 15;214(suppl 3):S308-S318
pubmed: 27601621
J Infect Dis. 2011 Nov;204 Suppl 3:S757-60
pubmed: 21987747
Science. 2016 Mar 4;351(6277):1078-83
pubmed: 26912366
Nat Med. 1999 Apr;5(4):423-6
pubmed: 10202932
PLoS Pathog. 2016 May 18;12(5):e1005656
pubmed: 27191716
J Infect Dis. 1999 Feb;179 Suppl 1:S108-14
pubmed: 9988173
Nat Med. 2019 Oct;25(10):1470-1471
pubmed: 31591604
Immunity. 2020 Feb 18;52(2):388-403.e12
pubmed: 32023489
JCI Insight. 2019 Nov 1;4(21):
pubmed: 31550241
Nat Immunol. 2003 Oct;4(10):1009-15
pubmed: 14502286
J Infect Dis. 2018 Nov 22;218(suppl_5):S508-S518
pubmed: 29986035
Am J Pathol. 2003 Dec;163(6):2347-70
pubmed: 14633608
Cell Death Dis. 2016 Mar 31;7:e2164
pubmed: 27031961
Immunol Rev. 2010 Mar;234(1):55-75
pubmed: 20193012
J Virol. 2015 Apr;89(8):4700-4
pubmed: 25673711
Nat Immunol. 2016 Oct;17(10):1226-34
pubmed: 27525369
J Immunol. 2009 Sep 15;183(6):3569-73
pubmed: 19717515
J Virol. 2020 Oct 14;94(21):
pubmed: 32817220
J Virol. 2017 Jul 27;91(16):
pubmed: 28592526
J Infect Dis. 2020 Jan 1;221(1):156-161
pubmed: 31301137
Nature. 2016 May 5;533(7601):100-4
pubmed: 27147028

Auteurs

Monika Rottstegge (M)

Bernhard Nocht Institute for Tropical Medicinegrid.424065.1, Hamburg, Germany.
German Center for Infection Research (DZIF) Partner Site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany.

Tom Tipton (T)

Pandemic Sciences Institute & Wellcome Centre for Human Genetics, University of Oxford, United Kingdom.

Lisa Oestereich (L)

Bernhard Nocht Institute for Tropical Medicinegrid.424065.1, Hamburg, Germany.
German Center for Infection Research (DZIF) Partner Site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany.

Paula Ruibal (P)

Department of Infectious Diseases, Leiden University Medical Centergrid.10419.3d, Leiden, The Netherlands.

Emily V Nelson (EV)

Bernhard Nocht Institute for Tropical Medicinegrid.424065.1, Hamburg, Germany.
German Center for Infection Research (DZIF) Partner Site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany.

Catherine Olal (C)

Bernhard Nocht Institute for Tropical Medicinegrid.424065.1, Hamburg, Germany.
German Center for Infection Research (DZIF) Partner Site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany.

Julia R Port (JR)

Bernhard Nocht Institute for Tropical Medicinegrid.424065.1, Hamburg, Germany.

Johan Seibel (J)

University Hospital Hamburg-Eppendorf, Institute for Transfusion Medicine, Hamburg, Germany.

Elisa Pallasch (E)

Bernhard Nocht Institute for Tropical Medicinegrid.424065.1, Hamburg, Germany.

Sabrina Bockholt (S)

Bernhard Nocht Institute for Tropical Medicinegrid.424065.1, Hamburg, Germany.

Fara Raymond Koundouno (FR)

Bernhard Nocht Institute for Tropical Medicinegrid.424065.1, Hamburg, Germany.
Laboratoire du Projet des Fièvres Hémorragiques de Guinée (PFHG), Conakry, Guinea.

Joseph Akoi Boré (JA)

Laboratoire du Projet des Fièvres Hémorragiques de Guinée (PFHG), Conakry, Guinea.

Estefanía Rodríguez (E)

Bernhard Nocht Institute for Tropical Medicinegrid.424065.1, Hamburg, Germany.
German Center for Infection Research (DZIF) Partner Site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany.

Beatriz Escudero-Pérez (B)

Bernhard Nocht Institute for Tropical Medicinegrid.424065.1, Hamburg, Germany.
German Center for Infection Research (DZIF) Partner Site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany.

Stephan Günther (S)

Bernhard Nocht Institute for Tropical Medicinegrid.424065.1, Hamburg, Germany.
German Center for Infection Research (DZIF) Partner Site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany.

Miles W Carroll (MW)

Pandemic Sciences Institute & Wellcome Centre for Human Genetics, University of Oxford, United Kingdom.
University Hospital Hamburg-Eppendorf, Institute for Transfusion Medicine, Hamburg, Germany.

César Muñoz-Fontela (C)

Bernhard Nocht Institute for Tropical Medicinegrid.424065.1, Hamburg, Germany.
German Center for Infection Research (DZIF) Partner Site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH